Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Xanthomonas is a genus of Gram-negative, rod-shaped Proteobacteria that serves as a major model for studying plant-pathogen interactions and is of significant interest in agricultural biotechnology (Wikipedia, 2024). These bacteria are characterized by their use of a Type III secretion system to deliver Transcription Activator-Like (TAL) effectors into host cells, which act as transcription factors to hijack host metabolism (Boch & Bonas, 2010). While Xanthomonas itself is not a human therapeutic target, its proteins—specifically TAL effectors—have been repurposed as TALENs for precision genome engineering in human therapeutics and research (Nature, 2011). In an agricultural context, Xanthomonas species cause devastating diseases such as rice bacterial blight and citrus canker, leading to substantial economic losses (Ryan et al., 2011). The genus is also the primary source of xanthan gum, an industrially vital polysaccharide used as a stabilizer in pharmaceutical formulations (Leyns et al., 1984). Current control strategies rely on bactericides and antibiotics like streptomycin, though the rise of resistance has spurred research into novel antimicrobial peptides and CRISPR-based control mechanisms (PubMed, 2021).
Inhibition of bacterial protein synthesis via 30S ribosomal subunit binding (aminoglycosides/tetracyclines) or non-specific protein denaturation and enzyme disruption by copper ions (PubMed, 2021; ScienceDirect, 2022).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Xanthomonas.